Liberate Bio bags key CAR-M patents, eyes first clinical trials in 2026
The licensed intellectual property covers methods and designs for CAR constructs engineered to function in myeloid cell populations
The licensed intellectual property covers methods and designs for CAR constructs engineered to function in myeloid cell populations
The trial met its primary endpoint, showing statistically significant improvements in Myasthenia Impairment Index (MGII) Patient-Reported Outcome (PRO) ocular scores at Week 4
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
Pivya is Alembic’s first branded pharmaceutica product in the US and is being marketed through Alembic Therapeutics LLC
It is also approved for?AIDS-related Kaposi sarcoma?after failure of highly active antiretroviral therapy, as well as for HIV-negative adult patients with Kaposi sarcoma
The 6th Edition NABH framework places strong emphasis on patient safety protocols, robust clinical governance, risk management systems
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales
Subscribe To Our Newsletter & Stay Updated